TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (Greenbrook or the Company), today announced its third quarter 2021 (Q3 2021) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated.<\/p>\n
THIRD QUARTER 2021 OPERATIONAL AND FINANCIAL HIGHLIGHTS<\/p>\n
Bill Leonard, President and Chief Executive Officer of Greenbrook commented:<\/p>\n
Q3 2021 presented specific challenges early in the quarter, with patients delaying treatment during the first open summer season since the onset of COVID-19 and a surge in the delta variant in late summer. Despite these challenges, we saw continued growth in both consolidated revenue and patient treatments in the quarter as compared to Q3 2020 as well as a strong bounce back in patient volumes in October 2021, tracking toward the record volumes that we experienced last quarter. We are also very excited about the acquisition of Achieve TMS East and Central as a foundation for future growth in New England and the central United States, and the promising prospects of the continued roll-out of our Spravato program to more of our active TMS Centers which we believe will enhance profit margins by optimizing the utilization of our current TMS Centers. These moves build on our long-term strategy of utilizing our growing network of TMS Centers and affiliated physicians as a services platform to deliver innovative treatments to patients suffering from mental health disorders. We believe that our business fundamentals remain sound, and we are positioned better than ever to serve the need for mental health support across the country, which we believe is at an all-time high.<\/p>\n
SELECTED THIRD QUARTER FINANCIAL AND OPERATING RESULTS (1)<\/p>\n
Selected Financial Results<\/p>\n
(US$) (unaudited)<\/p>\n
Q3 2021<\/p>\n
Q3 2020<\/p>\n
YTD 2021<\/p>\n
YTD 2020<\/p>\n
Total revenue<\/p>\n
13,130,245<\/p>\n
12,006,570<\/p>\n
38,150,632<\/p>\n
33,215,627<\/p>\n
Regional operating income (loss)<\/p>\n
249,057<\/p>\n
967,584<\/p>\n
(321,722)<\/p>\n
1,482,182<\/p>\n
Loss before income taxes<\/p>\n
(3,452,023)<\/p>\n
(7,667,755)<\/p>\n
(18,026,678)<\/p>\n
(21,643,193)<\/p>\n
Loss for the year and comprehensive loss<\/p>\n
(3,452,023)<\/p>\n
(7,667,755)<\/p>\n
(18,026,678)<\/p>\n
(21,643,193)<\/p>\n
Loss attributable to the common shareholders of Greenbrook<\/p>\n
(3,517,250)<\/p>\n
(7,636,132)<\/p>\n
(17,919,629)<\/p>\n
(21,271,910)<\/p>\n
Net loss per share (basic and diluted)(2)<\/p>\n
(0.22)<\/p>\n
(0.57)<\/p>\n
(1.23)<\/p>\n
(1.69)<\/p>\n
Notes:(1) Please note that additional selected consolidated financial information can be found at the end of this press release.(2) On January 12, 2021, the shareholders of the Company approved a special resolution for an amendment to the Companys articles and authorized a consolidation (the Share Consolidation) of the Companys outstanding Common Shares on the basis of one (1) post-consolidation Common Share for every five (5) pre-consolidation Common Shares. The Share Consolidation was completed on February 1, 2021. The Company has retrospectively presented net loss per share calculations reflecting the number of Common Shares outstanding after giving effect to the Share Consolidation.<\/p>\n
Selected Operating Results<\/p>\n<\/p>\n
As at September 30,<\/p>\n
As at September 30,<\/p>\n
As at December 31,<\/p>\n
(unaudited)<\/p>\n<\/p>\n
2021<\/p>\n<\/p>\n
2020<\/p>\n<\/p>\n
2020<\/p>\n
Number of active TMS Centers(1)<\/p>\n
127<\/p>\n
114<\/p>\n
116<\/p>\n
Number of TMS Centers-in-development(2)<\/p>\n
4<\/p>\n
11<\/p>\n
9<\/p>\n
Total TMS Centers<\/p>\n
131<\/p>\n
125<\/p>\n
125<\/p>\n
Number of management regions<\/p>\n
13<\/p>\n
13<\/p>\n
13<\/p>\n
Number of TMS Devices installed<\/p>\n
214<\/p>\n
191<\/p>\n
198<\/p>\n
Number of regional personnel<\/p>\n
350<\/p>\n
286<\/p>\n
305<\/p>\n
Number of shared-services \/ corporate personnel(3)<\/p>\n
58<\/p>\n
47<\/p>\n
49<\/p>\n
Number of TMS providers(4)<\/p>\n
126<\/p>\n
113<\/p>\n
117<\/p>\n
Number of consultations performed(5)<\/p>\n
10,561<\/p>\n
7,718<\/p>\n
11,305<\/p>\n
Number of patient starts(5)<\/p>\n
4,762<\/p>\n
4,017<\/p>\n
5,445<\/p>\n
Number of treatments performed(5)<\/p>\n
164,870<\/p>\n
141,584<\/p>\n
195,992<\/p>\n
Average revenue per treatment(5)<\/p>\n
<\/p>\n
Continue reading here:<\/p>\n
Greenbrook TMS Reports Third Quarter Operational and Financial Results - Business Wire<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (Greenbrook or the Company), today announced its third quarter 2021 (Q3 2021) operational and financial results. Continue reading